Offer - Urjas Oil for just ₹ 1 X
Libral (Scorsis) is an allopathic medicine The correct dosage of Libral (Scorsis) depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Libral (Scorsis) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Libral (Scorsis) safe for pregnant women?
Pregnant women may experience moderate side effects from Libral (Scorsis). It is best to stop taking Libral (Scorsis) immediately and inform your doctor if you notice any discomfort.
Is the use of Libral (Scorsis) safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Libral (Scorsis). Immediately discontinue Libral (Scorsis) if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Libral (Scorsis) on the Kidneys?
Libral (Scorsis) rarely affects the kidneys.
What is the effect of Libral (Scorsis) on the Liver?
Side effects of Libral (Scorsis) rarely affect the liver.
What is the effect of Libral (Scorsis) on the Heart?
Libral (Scorsis) may have mild side effects on the heart. Most people will never see any effect on the heart.
Libral (Scorsis) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Libral (Scorsis) unless your doctor advises you to do so -
Is this Libral (Scorsis) habit forming or addictive?
Yes, you can get addicted to Libral (Scorsis). It is essential that you take [medicine] only after doctor's recommendation.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Libral (Scorsis). So it is best to avoid driving.
Is it safe?
Libral (Scorsis) should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, Libral (Scorsis) is useful in treating mental disorders.
Interaction between Food and Libral (Scorsis)
You can take Libral (Scorsis) with food.
Interaction between Alcohol and Libral (Scorsis)
Consumption of alcohol and Libral (Scorsis) together may have severe effects on your health.
Yes Libral (Scorsis) causes drowsiness. It is one of the common side effects. If you are experiencing drowsiness after taking this drug, please inform your doctor immediately.
Libral (Scorsis) works by increasing the levels of a chemical messenger that is called serotonin in the brain which helps in regulating the mood and treating depression. It also stops the movement of the pain signal from the nerve to the brain. Hence, in this way, it treats depression and relieves neuropathic pain.
Discontinuing Libral (Scorsis) on your own can cause withdrawal symptoms. However, if you decide to stop it, then stop it slowly, and gradually. Do not stop suddenly. You are highly recommended to consult your doctor and check with him/her how to gradually decrease the dose, for example, 5mg of the dose is decreased every day when withdrawing this class of medicine. Do not decide the dose on your own seek medical help.
Libral (Scorsis) should be taken as prescribed by your doctor. However, it's best to take in the evening with or without food as this medicine induces sleep.
Yes, Libral (Scorsis) can cause stomach upset. Please inform your doctor if you are experiencing stomach upset after taking this medicine.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amitriptyline Hydrochloride
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 454,458
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 145-147
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Librium® C-IV (chlordiazepoxide HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 401-403
Package Leaflet [Internet]: LIBRIUM. Labiana Pharmaceuticals
Product Description [Internet]: LIMBITROL®. USFDA